This Book >>

  • 491pp. Published January 2016
  • Scientific Research Publishing
  • Category: Medicine & Healthcare
  • ISBN: 978-1-61896-148-8
  • (Hardcover) USD 109.00
  • ISBN: 978-1-61896-147-1
  • (Paperback) USD 89.00
Authors/Editors Price: 40% off
Buy at: bookorder@scirp.org

Connect with SCIRP >>

Home > Books > Type 2 Diabetes and Drug Therapy
Type 2 Diabetes and Drug Therapy
  • Description
  • Author(s) Information
In the present book, fifteen typical literatures about diabetes mellitus type 2 published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, hemadenology, virology, epidemiology, ect. We hope this book can demonstrate advances in diabetes mellitus type 2 as well as give references to the researchers, students and other related people.
Components of the Book:
  • FRONT MATTER
  • Chapter 1
    Epidemiology of Diabetes
  • Chapter 2
    Anti-Diabetic Effects of CTB-APSL Fusion Protein in Type 2
  • Chapter 3
    Induction of Heat Shock Proteins in the Therapy of Type 2 Diabetes and Metabolic Syndrome
  • Chapter 4
    Obesity and Risk Factors for Cardiovascular Disease and Type 2 Diabetes: Investigating the Role of Physical Activity and Sedentary Behaviour in Mid-Life in the 1958 British Cohort
  • Chapter 5
    Naringenin Accords Hepatoprotection from Streptozotocin Induced Diabetes in Vivo by Modulating Mitochondrial Dysfunction and Apoptotic Signaling Cascade
  • Chapter 6
    The Use of Plants in the Traditional Management of Diabetes in Nigeria: Pharmacological and Toxicological Considerations
  • Chapter 7
    Light Therapy for Better Mood and Insulin Sensitivity in Patients with Major Depression and Type 2 Diabetes: A Randomised, Double-Blind, Parallel-Arm Trial
  • Chapter 8
    Determinants of Saxagliptin Use among Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-Diabetic Drugs
  • Chapter 9
    Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients with Inadequately Controlled Type 2 Diabetes on Oral Antidiabetic Drugs in Greece
  • Chapter 10
    Cardiovascular Safety of Linagliptin in Type 2 Diabetes: A Comprehensive Patient-Level Pooled Analysis of Prospectively Adjudicated Cardiovascular Events
  • Chapter 11
    Antihyperglycaemic Treatment Patterns, Observed Glycaemic Control and Determinants of Treatment Change among Patients with Type 2 Diabetes in the United Kingdom Primary Care: A Retrospective Cohort Study
  • Chapter 12
    The Expanding Role of Aerosols in Systemic Drug Delivery, Gene Therapy and Vaccination: An Update
  • Chapter 13
    Effect of Nonsurgical Periodontal Therapy Verses Oral Hygiene Instructions on Type 2 Diabetes Subjects with Chronic Periodontitis: A Randomised Clinical Trial
  • Chapter 14
    Diagnosis and Management of Non-Alcoholic Fatty Liver Disease and Related Metabolic Disorders: Consensus Statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology
Readership: Clinical practitioners and scientists; medical and medicinal students; medicinal researchers and those with an interest in treatment of diabetes.
comments powered by Disqus